LONDON, 1st July 2009-- "The Medical House PLC (“TMH”), (AIM:MLH) the specialist drug delivery company, announces that it has now supplied Merck Serono, a division of Merck KGaA, Darmstadt, Germany, with an advanced needle-free jet injector system specifically designed and manufactured to their specification. The system, known as “cool.click?” incorporates a number of features not previously associated with needle-free devices, such as an innovative dose display. In addition, an enhanced security system allows for safe injection while the level of noise associated with the injection has been minimised..."
"In October 2008 TMH announced a non-exclusive development, licence and supply agreement with Catalent Pharma Solutions and Stallergenes to develop and distribute a variation of the company’s core disposable autoinjector technology for use with epinephrine. Under the terms of this agreement, TMH will customise its proprietary, patented ASITM disposable autoinjector device technology, according to an agreed specification and will be combined with epinephrine supplied by Catalent to create epinephrine autoinjectors for both adult and paediatric use.
These epinephrine autoinjectors are intended for the emergency treatment of anaphylactic shock, mostly due to hymenoptera venom or food allergies and for the use by patients themselves or by a person close to the patient in the event of an emergency. The newly-created product will be distributed exclusively by Stallergenes who are a European biopharmaceutical company, with annual sales in 2007 of ?? million, dedicated to desensitisation therapies for the prevention and treatment of allergy-related conditions. The Agreement covers 13 European countries, including the United Kingdom and incorporates provision for extension to additional territories."
Read entire article here... http://www.pharmalive.com/News/index.cfm?articleid=637156&categoryid=54